Securities law firm investigates multiple companies for alleged misleading statements and omissions affecting financial forecasts and operational realities.
Merck secures global rights to a promising obesity drug in a $2 billion deal with China's Hansoh Pharma, positioning the company to compete in the rapidly growing obesity treatment market.
Securities law firm investigates multiple companies for alleged misleading statements and omissions affecting financial forecasts and operational realities.
Merck secures global rights to a promising obesity drug in a $2 billion deal with China's Hansoh Pharma, positioning the company to compete in the rapidly growing obesity treatment market.